IDBS expands use of BioBook with leading biotechnology company

Guildford, UK, November 16 2006 – IDBS today announced that Serono SA has chosen to expand its use of IDBS’ electronic study management tool BioBook.

 

Serono, a global biotechnology leader, chose BioBook after evaluating a number of options that were “very chemistry focused”. Serono became one of the first companies to start using BioBook back in December 2005 because of its unique integration of biological functionality and chemistry tools, and its specific ability to handle preclinical science. Following a successful initial roll out, Serono has now decided to more than double its number of BioBook users.

Dr Valérie Barbié, Head of Scientific Computing at Serono Preclinical Development, commented: “What impressed us about BioBook was the application focus on preclinical science. The system is functionally comparable to Excel, but with BioBook, you are able to define access and user rights.”

 

Neil Kipling, founder and CEO of IDBS, added: “We are very pleased to work with specialists like Serono’s biologists. We offer them a unique integration tool with advanced data management, analysis and reporting capabilities that has saved them significant time and money.”

 

IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximising the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.

 

Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide.

 

BioBook is a complete data management system for late stage discovery, pharmacology and early preclinical research. It simplifies the management of complex research data, enhancing the productivity of biologists by providing a compliant flexible environment that controls every stage of the study lifecycle.